Hepatitis B Virus Antibody Levels 7 to 9 Years after Booster Vaccination in Alaska Native Persons

被引：12
|
作者：
Keck, James W. [1 ,2 ]
Bulkow, Lisa R. [2 ]
Raczniak, Gregory A. [1 ,2 ]
Negus, Susan E. [3 ]
Zanis, Carolyn L. [2 ]
Bruce, Michael G. [2 ]
Spradling, Philip R. [4 ]
Teshale, Eyasu H. [4 ]
McMahon, Brian J. [2 ,3 ]
机构：
[1] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA
[2] Ctr Dis Control & Prevent, Arctic Invest Program, Anchorage, AK USA
[3] Alaska Native Tribal Hlth Consortium, Liver Dis & Hepatitis Program, Anchorage, AK USA
[4] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA USA
来源：
CLINICAL AND VACCINE IMMUNOLOGY | 2014年 / 21卷 / 09期
关键词：
PROTECTION; CHILDREN; IMPACT;
D O I：
10.1128/CVI.00263-14
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Hepatitis B antibody persistence was assessed in individuals who had previously received a vaccine booster. We measured hepatitis B surface antigen antibody (anti-HBs) levels 7 to 9 years post-hepatitis B booster in individuals with primary vaccination at birth. While 95 (91.3%) of 104 participants had detectable anti-HBs (minimum, 0.1 mIU/ml; maximum, 1,029 mIU/ml), only 43 (41%) had protective levels of >= 10 mIU/ml. Pre- and week 4 postbooster anti-HBs levels were significant predictors of hepatitis B immunity at follow-up (P < 0.001). Almost all participants had detectable anti-HBs 7 to 9 years after the hepatitis B vaccine booster, but less than half had levels >= 10 mIU/ml.
引用
收藏
页码：1339 / 1342
页数：4
相关论文
共 50 条
  • [1] Declining antibody levels after hepatitis B vaccination in Down syndrome: A need for booster vaccination?
    Eijsvoogel, Noortje B.
    Hollegien, Mirjam I.
    Bok, Vinus L. A.
    Derksen-Lubsen, Arda G.
    Dikken, Felix P. J.
    Leenders, Sander A. C. A. P.
    Pijning, Arjan
    Post, Erica
    Wojciechowski, Marek
    Hilbink, Mirrian
    de Vries, Esther
    JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (09) : 1682 - 1685
  • [2] Linkage to Care for Alaska Native Persons with Chronic Hepatitis B Virus
    McMahon, Brian J.
    Townshend-Bulson, Lisa J.
    Homan, Chriss E.
    Gounder, Prabhu P.
    Negus, Susan
    Snowball, Mary M.
    Barbour, Youssef
    Simons, Brenna
    HEPATOLOGY, 2017, 66 : 1018A - 1018A
  • [3] Vaccination Status of Alaska Native Persons With Hepatitis A Virus Infection-Alaska, 1996-2018
    Plumb, Ian D.
    Gounder, Prabhu P.
    Nolen, Leisha D.
    Massay, Stephanie C.
    Castrodale, Louisa
    McLaughlin, Joseph
    Snowball, Mary
    Homan, Chriss
    Nelson, Noele P.
    Singleton, Rosalyn
    Bruce, Michael G.
    McMahon, Brian J.
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (12) : 2212 - 2214
  • [4] Antibody levels in Ethiopian children five years after vaccination with two different doses of hepatitis B vaccine: Is there a need for booster vaccine?
    Tsega, E
    Horton, J
    Nordenfelt, E
    Hansson, BJ
    Tafesse, B
    Wolde-Hawariat, G
    Lindberg, J
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 1998, 12 (01): : 57 - 60
  • [5] Antibody levels against hepatitis B virus after hepatitis B vaccination in Egyptian diabetic children and adolescents
    Elrashidy, Heba
    Elbahrawy, Ashraf
    El-Didamony, Gamal
    Mostafa, Mohamed
    George, Nilly M.
    Elwassief, Ahmed
    Mohamed, Abdel-Gawad Saeid
    Elmestikawy, Amr
    Morsy, Mohamed Hanafy
    Hashim, Alaa
    Abdelbasseer, Mohamed Ali
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (09) : 2002 - 2006
  • [6] The necessity of booster vaccination after neonatal hepatitis B vaccination
    Lankarani, Kamran Bagheri
    HEPATITIS MONTHLY, 2011, 11 (06) : 419 - 421
  • [7] Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose
    Bruce, Michael G.
    Bruden, Dana
    Hurlburt, Debby
    Morris, Julie
    Bressler, Sara
    Thompson, Gail
    Lecy, Danielle
    Rudolph, Karen
    Bulkow, Lisa
    Hennessy, Thomas
    Simons, Brenna C.
    Weng, Mark K.
    Nelson, Noele
    McMahon, Brian J.
    HEPATOLOGY, 2022, 76 (04) : 1180 - 1189
  • [8] Effectiveness of a Statewide Hepatitis B Virus (HBV) Vaccination Program in Preventing Symptomatic HBV Infection Among Alaska Native (AN) Persons, Alaska 1987-2011
    Gounder, Prabhu P.
    Snowball, Mary M.
    Spradling, Philip R.
    Negus, Susan
    Schillie, Sarah
    McMahon, Brian J.
    HEPATOLOGY, 2017, 66 : 1001A - 1001A
  • [9] Persistence of antibody to Hepatitis A virus 20years after receipt of Hepatitis A vaccine in Alaska
    Plumb, I. D.
    Bulkow, L. R.
    Bruce, M. G.
    Hennessy, T. W.
    Morris, J.
    Rudolph, K.
    Spradling, P.
    Snowball, M.
    McMahon, B. J.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 (07) : 608 - 612
  • [10] Is a Booster Dose of Primary Vaccination against Hepatitis B Necessary After Five Years?
    Tosun, Selma
    Aksu, Selahattin
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2009, 14 (03): : 98 - 103
12345